Evidence map›Paper›PMID 34297286›Full record

ArticleBulletin of experimental biology and medicine2021

Role of NMDA Receptors and Protein Synthesis in the Conditioned Aversion Learning in Young Chicks.

А А Tiunova, D V Bezryadnov, А B Cherepov

Abstract read
PubMed Publisher
In one paragraph

Article in Bulletin of experimental biology and medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 95% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Experimental modeling of Alzheimer's disease: Translational lessons from cross-taxon analyses.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

А А TiunovaP. K. Anokhin Research Institute of Normal Physiology, Moscow, Russia. aat699@yahoo.com.
D V BezryadnovP. K. Anokhin Research Institute of Normal Physiology, Moscow, Russia.
А B CherepovKurchatov Complex of NBICS-Technologies, National Research Center "Kurchatov Institute", Moscow, Russia.
Institute of Normal Physiology named after P.K. Anokhin · RUKurchatov Institute · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The brain mechanisms underlying conditioned aversion learning in birds were studied using experimental model in young chicks. The learning consisted of a conditioning stimulus presentation followed by a delayed sickness-inducing treatment reinforcement. Intraventricular administration of an NMDA receptor antagonist MK-801, a protein synthesis inhibitor anisomycin, or an inhibitor of glycoprotein fucosylation 2-deoxygalactose just before presentation of the conditioning stimulus prevented aversion learning. Injections of the same chemicals before reinforcement did not affect learning. The obtained results show that the investigated mechanisms underlying aversion learning were critical at the early stage of memory formation. Later processes of association of the conditioning stimulus with the reinforcement appear to be independent of the NMDA receptors and protein synthesis/glycosylation, or alternatively to be located in other brain areas.

Indexed as

AnimalsAnimals, NewbornAnisomycinAvoidance LearningBrainChickensConditioning, PsychologicalDizocilpine MaleateExcitatory Amino Acid AntagonistsFucoseGene ExpressionGlycosylationInjections, IntraventricularLithium ChlorideMemory, Long-TermProtein BiosynthesisAnisomycinDizocilpine MaleateExcitatory Amino Acid AntagonistsFucoseLithium ChlorideProtein Synthesis InhibitorsReceptors, N-Methyl-D-Aspartatechicksconditioned aversionlearningNMDA receptorsprotein synthesis

Identifiers

PMID34297286
OpenAlexW3139279483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.